Showing results (291-300 of 560) with videos related to

Sort By:
Pageof 56
Blut|October 1, 1975
The effect of heparin on platelet aggregation by common inductors and by ristocetin in congenital bleeding disorders due to factor VIII or fibrinogen defectsA Girolami, L De Marco, L Virgolini, et al.
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1983
A statistical analysis of some thromboelastographic parameters in normal subjectsM Procidano, R Martino, G da Rin, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 1, 1991
Use of a radioimmunoassay for 5-hydroxytryptamine (5-HT) in thrombocytosisM L Randi, F Stocco, T Tison, et al.
Acta Haematologica|June 28, 2008
Control of ovulation-induced hemoperitoneum by oral contraceptives in a patient with congenital hypoprothrombinemia and in another with congenital factor V deficiencyA Girolami, A M Lombardi, N Candeo, et al.
Journal of Thrombosis and Thrombolysis|April 9, 2005
Pregnancies and oral contraceptive therapy in severe (homozygons) FXII deficiency: a study in 12 patients and review of the literatureA Girolami, N Zocca, B Girolami, et al.
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1985
The effect of different doses of 32P in the treatment of primary thrombocytosisM L Randi, F Fabris, L Varotto, et al.
Blut|April 1, 1980
Hemophilia B with associated factor VII deficiency: a distinct variant of hemophilia B with low factor VII activity and normal factor VII antigenA Girolami, R Dal Bo Zanon, L De Marco, et al.
Minerva Anestesiologica|February 13, 2014
Thromboelastometry for guiding bleeding management of the critically ill patient: a systematic review of the literatureT Haas, K Görlinger, A Grassetto, et al.
International Journal of Laboratory Hematology|September 11, 2012
Factor VIIa-antithrombin complexes in patients with non-neoplastic portal vein thrombosis with and without cirrhosisV Rossetto, L Spiezia, M Senzolo, et al.
The Journal of Biological Chemistry|August 15, 1997
Increased tissue factor-initiated prothrombin activation as a result of the Arg506 --> Gln mutation in factor VLEIDENC van 't Veer, M Kalafatis, R M Bertina, et al.
Pageof 56